PG
CVS icon

PEAK6 Group’s CVS Health CVS Stock Holding History

PEAK6 Group’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		$9.12M Sell
141,694
-74,717
-35% -$4.92M 0.04% 479
2018
Q1 		$13.5M Buy
216,411
+103,007
+91% +$7.39M 0.06% 342
2017
Q4 		$8.22M Buy
+113,404
New +$8.24M 0.04% 560
2017
Q3 		– Sell
-98,539
Closed -$7.79M – 4492
2017
Q2 		$7.93M Sell
98,539
-13,310
-12% -$1.05M 0.05% 476
2017
Q1 		$8.78M Buy
111,849
+6,898
+7% +$551K 0.07% 330
2016
Q4 		$8.28M Buy
104,951
+36,611
+54% +$2.96M 0.06% 443
2016
Q3 		$6.08M Buy
68,340
+30,937
+83% +$2.92M 0.05% 586
2016
Q2 		$3.58M Buy
+37,403
New +$3.73M 0.03% 857
2015
Q3 		– Sell
-9,873
Closed -$1.04M – 5190
2015
Q2 		$1.03M Buy
+9,873
New +$1.01M 0.01% 2055
2014
Q4 		– Sell
-1,616
Closed -$142K – 4722
2014
Q3 		$129K Buy
+1,616
New +$127K ﹤0.01% 3629
2014
Q1 		– Sell
-66,033
Closed -$4.66M – 4963
2013
Q4 		$4.73M Buy
+66,033
New +$4.24M 0.03% 766

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

PEAK6 Group's CVS Position: Q2 2018 in Review

PEAK6 Group reduced its CVS Health (CVS) stake by 35% in Q2 2018, selling an estimated $4.92M and leaving 141,694 shares worth $9.12M. The position accounts for 0.04% of the portfolio, ranked #479.

PEAK6 Group first reported a position in CVS in Q4 2013 and has held it in 11 quarters since. The position peaked at $13.5M in Q1 2018. 1,572 funds tracked by Wall St. Rank hold CVS as of Q2 2018.

  • PEAK6 Group held 141,694 shares of CVS Health worth $9.12M as of Q2 2018.
  • PEAK6 Group sold 74,717 CVS Health shares in Q2 2018, an estimated $4.92M.
  • CVS Health made up 0.04% of PEAK6 Group's portfolio in Q2 2018, its #479 holding.
  • PEAK6 Group first reported a position in CVS Health in Q4 2013 and has held it in 11 quarters since.
  • PEAK6 Group's CVS Health position peaked at $13.5M in Q1 2018.
  • 1,572 funds tracked by Wall St. Rank held CVS Health as of Q2 2018.

Based on PEAK6 Group's 13F filing for Q2 2018, filed 15 Aug 2018.